169 related articles for article (PubMed ID: 10858439)
21. Control of myeloid differentiation and survival by Stats.
Smithgall TE; Briggs SD; Schreiner S; Lerner EC; Cheng H; Wilson MB
Oncogene; 2000 May; 19(21):2612-8. PubMed ID: 10851060
[TBL] [Abstract][Full Text] [Related]
22. Involvement of casein kinase Iepsilon in cytokine-induced granulocytic differentiation.
Okamura A; Iwata N; Nagata A; Tamekane A; Shimoyama M; Gomyo H; Yakushijin K; Urahama N; Hamaguchi M; Fukui C; Chihara K; Ito M; Matsui T
Blood; 2004 Apr; 103(8):2997-3004. PubMed ID: 15070676
[TBL] [Abstract][Full Text] [Related]
23. Differential roles of SOCS family members in EpoR signal transduction.
Jegalian AG; Wu H
J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
[TBL] [Abstract][Full Text] [Related]
24. Response to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surface.
Migliaccio AR; Migliaccio G; D'Andrea A; Baiocchi M; Crotta S; Nicolis S; Ottolenghi S; Adamson JW
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11086-90. PubMed ID: 1722318
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2.
Valk P; Verbakel S; von Lindern M; Löwenberg B; Delwel R
Hematol J; 2000; 1(4):254-63. PubMed ID: 11920199
[TBL] [Abstract][Full Text] [Related]
26. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
27. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
[TBL] [Abstract][Full Text] [Related]
28. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells.
Shimozaki K; Nakajima K; Hirano T; Nagata S
J Biol Chem; 1997 Oct; 272(40):25184-9. PubMed ID: 9312131
[TBL] [Abstract][Full Text] [Related]
29. Hematopoietic cell-type-dependent regulation of leukocyte integrin functional activity: CD11b and CD11c expression inhibits LFA-1-dependent aggregation of differentiated U937 cells.
Nueda A; López-Rodríguez C; Rubio MA; Sotillos M; Postigo A; del Pozo MA; Vega MA; Corbí AL
Cell Immunol; 1995 Sep; 164(2):163-9. PubMed ID: 7656323
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
31. Roles for an Epo receptor Tyr-343 Stat5 pathway in proliferative co-signaling with kit.
Li K; Miller C; Hegde S; Wojchowski D
J Biol Chem; 2003 Oct; 278(42):40702-9. PubMed ID: 12909618
[TBL] [Abstract][Full Text] [Related]
32. Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules.
Giron-Michel J; Caignard A; Fogli M; Brouty-Boyé D; Briard D; van Dijk M; Meazza R; Ferrini S; Lebousse-Kerdilès C; Clay D; Bompais H; Chouaib S; Péault B; Azzarone B
Blood; 2003 Jul; 102(1):109-17. PubMed ID: 12623850
[TBL] [Abstract][Full Text] [Related]
33. [Quantitative expression of the adhesion receptors VLA-4, VLA-5, L-selectin, MAC-1, and ICAM-1 on the surface of CD34+ cells].
Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
Transfus Clin Biol; 2001 Dec; 8(6):453-9. PubMed ID: 11802606
[TBL] [Abstract][Full Text] [Related]
34. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
35. Cytokine-induced phosphoinositide 3-kinase activity promotes Cdk2 activation in factor-dependent hematopoietic cells.
Henry MK; Nimbalkar D; Hohl RJ; Quelle FW
Exp Cell Res; 2004 Sep; 299(1):257-66. PubMed ID: 15302592
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
37. [Constitutive activation of MAP kinase pathway and STAT pathway in AML].
Towatari M; Iida H
Rinsho Ketsueki; 1998 Feb; 39(2):86-8. PubMed ID: 9545805
[No Abstract] [Full Text] [Related]
38. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
Haq R; Halupa A; Beattie BK; Mason JM; Zanke BW; Barber DL
J Biol Chem; 2002 May; 277(19):17359-66. PubMed ID: 11875080
[TBL] [Abstract][Full Text] [Related]
39. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
Klausen P; Pedersen L; Jurlander J; Baumann H
Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
[TBL] [Abstract][Full Text] [Related]
40. Constitutive activation of STAT3 and STAT5 is induced by leukemic fusion proteins with protein tyrosine kinase activity and is sufficient for transformation of hematopoietic precursor cells.
Spiekermann K; Pau M; Schwab R; Schmieja K; Franzrahe S; Hiddemann W
Exp Hematol; 2002 Mar; 30(3):262-71. PubMed ID: 11882364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
